InvestorsHub Logo
Followers 3
Posts 675
Boards Moderated 0
Alias Born 05/11/2011

Re: goforthebet post# 35567

Tuesday, 07/22/2014 9:31:37 AM

Tuesday, July 22, 2014 9:31:37 AM

Post# of 52074
Quote: "not mentioned which one. Hope it was from MZEI"

1) It DOES mention which one:

Quote (Gallery 4/11): "Medical technologist Matt Wierenga is reflected on a GeneXpert Infinity machine [ http://www.cepheid.com/us/cepheid-solutions/systems/genexpert-infinity/genexpert-infinity-48s/64?view=products ] as he operates it at Mercy Health Saint Mary's Monday, Feb. 3, 2014. The new lab machine, a molecular diagnostics system, can quickly process tests determining if a patient has an infection."

-----

2) IMPOSSIBLE TO HAVE COME "from MZEI":(Any suggestion that MZEI manufactures patient screening technology for hospitals is FALSE and MISLEADING)

Not only does Medizone NOT manufacture patient screening technology for hospitals/labs it does not have the ability/resources to manufacture complex molecular diagnostic systems similar to those purchased by Saint Mary's http://www.cepheid.com/administrator/components/com_productcatalog/library-files/c6eaab3966633982970caff55240de75-GeneXpert-Infinity-Systems-US-0392-02.pdf

-----

The very thought of Medizone, already challenged in designing and manufacturing disinfection equipment, (which Chairman/CEO Edwin Marshall [ex Fireman/Car Salesman] described as a "simple device") attempting to design and manufacture complex molecular diagnostic systems is laughable...NOT ONE(1) SALE TO A HOSPITAL NOR ONE(1) HOSPITAL SERVICE CONTRACT HAS BEEN REPORTED (The manufacture of the first production machine was announced back in April 2012)

---------------

Transparency or confusion? Debating the merits of hospital-acquired infections reporting

http://www.mlive.com/news/grand-rapids/index.ssf/2014/06/transparency_or_confusion_west.html

Patients asking questions

The infection-control specialists say they field an increasing number of calls from patients worried about infection risks. Some have questions about data they have seen on infection rates.

“You hear the frustration in their voices because it’s a difficult topic for people in the hospital to discuss,” Greenwald said. “What I like to discuss are the process measures we put in place to prevent infections from occurring. They are always grateful to hear that.”

Those processes might include having the patient take antibiotics or shower with an antiseptic soap before surgery. Patients may be screened to see if they are “colonized” with a staph infection, which would put them at greater risk of infection in surgery.

Saint Mary’s recently added new lab equipment that allows doctors to get results on MRSA and C.diff tests in hours, rather than in days. (not mentioned which one. Hope it was from MZEI)

The more quickly staff finds out a patient has a C.diff infection, the more quickly an infected patient can be put into contact isolation. Nurses and doctors treating the patient wear gowns and gloves. The environmental services staff has special cleaning agents for the room after the patient leaves.





Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.